Artwork for podcast Prostate Cancer Update
PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida
Episode 39 • 15th May 2026 • Prostate Cancer Update • Dr. Neil Love
00:00:00 00:51:55

Share Episode

Shownotes

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.

CME information and select publications here.

Follow

Links

Chapters

Video

More from YouTube